CN102159587B - 假脯氨酸二肽 - Google Patents

假脯氨酸二肽 Download PDF

Info

Publication number
CN102159587B
CN102159587B CN2009801367246A CN200980136724A CN102159587B CN 102159587 B CN102159587 B CN 102159587B CN 2009801367246 A CN2009801367246 A CN 2009801367246A CN 200980136724 A CN200980136724 A CN 200980136724A CN 102159587 B CN102159587 B CN 102159587B
Authority
CN
China
Prior art keywords
formula
acid
hydrogen
water
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009801367246A
Other languages
English (en)
Chinese (zh)
Other versions
CN102159587A (zh
Inventor
S·希尔德布兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN102159587A publication Critical patent/CN102159587A/zh
Application granted granted Critical
Publication of CN102159587B publication Critical patent/CN102159587B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
CN2009801367246A 2008-10-07 2009-09-29 假脯氨酸二肽 Expired - Fee Related CN102159587B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08165968 2008-10-07
EP08165968.2 2008-10-07
PCT/EP2009/062568 WO2010040660A1 (en) 2008-10-07 2009-09-29 Pseudoproline dipeptides

Publications (2)

Publication Number Publication Date
CN102159587A CN102159587A (zh) 2011-08-17
CN102159587B true CN102159587B (zh) 2013-11-13

Family

ID=41202596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801367246A Expired - Fee Related CN102159587B (zh) 2008-10-07 2009-09-29 假脯氨酸二肽

Country Status (12)

Country Link
US (1) US8153815B2 (ko)
EP (1) EP2344516B1 (ko)
JP (1) JP5389930B2 (ko)
KR (1) KR101268794B1 (ko)
CN (1) CN102159587B (ko)
AU (1) AU2009301209B2 (ko)
BR (1) BRPI0919501A2 (ko)
CA (1) CA2737675C (ko)
ES (1) ES2410267T3 (ko)
IL (1) IL210799A (ko)
MX (1) MX2011002913A (ko)
WO (1) WO2010040660A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103524595A (zh) * 2013-10-14 2014-01-22 苏州维泰生物技术有限公司 公斤级新方法合成伪二肽Fmoc-Gly-Thr(ψMe, Me pro)-OH的方法
CN103897024A (zh) * 2014-02-28 2014-07-02 苏州维泰生物技术有限公司 一种合成丙氨酸丝氨酸伪二肽模块的新方法
CN106432468A (zh) * 2016-11-03 2017-02-22 滨海吉尔多肽有限公司 一种制备艾塞那肽的固相合成方法
CN107176970B (zh) * 2017-07-06 2019-11-19 中国医药集团总公司四川抗菌素工业研究所 一种树脂催化法合成伪脯氨酸杂环肽的方法
DK3517543T3 (da) * 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
CN109836476A (zh) * 2019-03-20 2019-06-04 吉尔生化（上海）有限公司 一种半胱氨酸假脯氨酸二肽的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008000641A1 (en) * 2006-06-28 2008-01-03 F. Hoffmann-La Roche Ag Pseudo proline dipeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60028936T2 (de) 1999-02-05 2007-01-11 Debiopharm S.A. Cyclosporin-derivate und verfahren zu deren herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008000641A1 (en) * 2006-06-28 2008-01-03 F. Hoffmann-La Roche Ag Pseudo proline dipeptides

Also Published As

Publication number Publication date
IL210799A (en) 2015-10-29
WO2010040660A1 (en) 2010-04-15
JP2012504154A (ja) 2012-02-16
CA2737675C (en) 2016-02-09
EP2344516A1 (en) 2011-07-20
IL210799A0 (en) 2011-04-28
BRPI0919501A2 (pt) 2015-12-08
MX2011002913A (es) 2011-04-12
CA2737675A1 (en) 2010-04-15
US20100087654A1 (en) 2010-04-08
EP2344516B1 (en) 2013-03-20
US8153815B2 (en) 2012-04-10
KR20110061604A (ko) 2011-06-09
CN102159587A (zh) 2011-08-17
AU2009301209A1 (en) 2010-04-15
AU2009301209B2 (en) 2012-11-08
KR101268794B1 (ko) 2013-05-28
JP5389930B2 (ja) 2014-01-15
ES2410267T3 (es) 2013-07-01

Similar Documents

Publication Publication Date Title
CN102159587B (zh) 假脯氨酸二肽
AU2018240467B2 (en) Peptide nucleic acid (PNA) monomers with an orthogonally protected ester moiety
WO2019018422A1 (en) MONOMERS OF PEPTIDE NUCLEIC ACID (PNA) WITH AN ESTER FRACTION WITH ORTHOGONAL PROTECTION, NOVEL INTERMEDIATES AND RELATED METHODS
JP5292289B2 (ja) シュードプロリンジペプチド
SK283042B6 (sk) Spôsob redukčnej aminácie
US6639094B2 (en) Process for producing α-aminoketone derivatives
EP2161277A2 (en) Asymmetric synthesis of peptides
EP3067430B1 (en) Method for producing d-form or l-form amino acid derivative having thiol group
CN108864252B (zh) 制备nrx-1074的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131113

Termination date: 20180929